Molina Healthcare Inc. (NYSE: MOH), a managed care company focused on providing healthcare services to low-income individuals, on Monday reported preliminary results for the second quarter of fiscal 2025.
- Molina now expects second-quarter 2025 adjusted earnings to be around $5.50 per share, which is slightly below its previous guidance
- The company has experienced medical cost pressures in all three lines of its business, and the trend is expected to continue into the second half of the year
- The management forecasts full-year 2025 adjusted earnings in the range of $21.50 to $22.50 per share
- The forecast for full-year consolidated pre-tax margin is just under 4%, which comes at the low end of the company’s long-term guidance range
- The short-term earnings pressure reflects a temporary dislocation between premium rates and medical cost trend, which has recently accelerated
- Molina is scheduled to report final second-quarter 2025 results on July 23, 2025, after the closing bell
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Key metrics from Kroger’s (KR) Q3 2025 earnings results
The Kroger Co. (NYSE: KR) reported its third quarter 2025 earnings results today. Total company sales rose to $33.9 billion from $33.6 billion in the same period last year. Identical
Dollar General (DG) Q3 2025 Earnings: Key financials and quarterly highlights
Dollar General Corporation (NYSE: DG) reported its third quarter 2025 earnings results today. Net sales increased 4.6% year-over-year to $10.65 billion. Same-store sales increased 2.5%. Net income was $282.7 million, or
HRL Earnings: All you need to know about Hormel Foods’ Q4 2025 earnings results
Hormel Foods Corporation (NYSE: HRL) reported its fourth quarter 2025 earnings results today. Net sales increased 1.5% year-over-year to $3.18 billion. Organic sales were up 2%. Net loss attributable to Hormel